128 related articles for article (PubMed ID: 23208589)
1. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
Baker BG; Ball GR; Rakha EA; Nolan CC; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):127-37. PubMed ID: 23208589
[TBL] [Abstract][Full Text] [Related]
2. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
[TBL] [Abstract][Full Text] [Related]
3. Calpain system protein expression in basal-like and triple-negative invasive breast cancer.
Storr SJ; Lee KW; Woolston CM; Safuan S; Green AR; Macmillan RD; Benhasouna A; Parr T; Ellis IO; Martin SG
Ann Oncol; 2012 Sep; 23(9):2289-2296. PubMed ID: 22745213
[TBL] [Abstract][Full Text] [Related]
4. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
5. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
Li Y; Yang W; Yang Q; Zhou S
Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
[TBL] [Abstract][Full Text] [Related]
7. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
8. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
[TBL] [Abstract][Full Text] [Related]
9. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.
Turashvili G; McKinney SE; Goktepe O; Leung SC; Huntsman DG; Gelmon KA; Los G; Rejto PA; Aparicio SA
Mod Pathol; 2011 Jan; 24(1):64-81. PubMed ID: 20852590
[TBL] [Abstract][Full Text] [Related]
10. Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1.
Arnes JB; Collett K; Akslen LA
Histopathology; 2008 Feb; 52(3):370-80. PubMed ID: 18269588
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Agboola AJ; Musa AA; Wanangwa N; Abdel-Fatah T; Nolan CC; Ayoade BA; Oyebadejo TY; Banjo AA; Deji-Agboola AM; Rakha EA; Green AR; Ellis IO
Breast Cancer Res Treat; 2012 Sep; 135(2):555-69. PubMed ID: 22842985
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
13. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.
Khoshnaw SM; Rakha EA; Abdel-Fatah T; Nolan CC; Hodi Z; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):139-53. PubMed ID: 23225145
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
15. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
16. Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.
Thike AA; Iqbal J; Cheok PY; Chong AP; Tse GM; Tan B; Tan P; Wong NS; Tan PH
Am J Surg Pathol; 2010 Jul; 34(7):956-64. PubMed ID: 20495445
[TBL] [Abstract][Full Text] [Related]
17. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
El-Gendi SM; Mostafa MF
Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
[TBL] [Abstract][Full Text] [Related]
18. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
19. Expression of XB130 in human ductal breast cancer.
Li J; Sun W; Wei H; Wang X; Li H; Yi Z
Int J Clin Exp Pathol; 2015; 8(5):5300-8. PubMed ID: 26191231
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of basal cytokeratin expression in operable breast cancer.
Potemski P; Kusinska R; Watala C; Pluciennik E; Bednarek AK; Kordek R
Oncology; 2005; 69(6):478-85. PubMed ID: 16410686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]